Zobrazeno 1 - 9 of 9 pro vyhledávání: '"Myrna L. Cozen"'
1
Akademický článek
Nonresponse to interferon-α based treatment for chronic hepatitis C infection is associated with increased hazard of cirrhosis.
Autor: Myrna L Cozen, James C Ryan, Hui Shen, Robert Lerrigo, Russell M Yee, Edward Sheen, Richard Wu, Alexander Monto
Publikováno v: PLoS ONE, Vol 8, Iss 4, p e61568 (2013)
The long-term consequences of unsuccessful interferon-α based hepatitis C treatment on liver disease progression and survival have not been fully explored.We performed retrospective analyses to assess long-term clinical outcomes among treated and un
Externí odkaz: https://doaj.org/article/cbf17b62f3834891adba360f4f63f098
Zobrazit plný text záznamu
2
CCR2 Deficiency Impairs Macrophage Infiltration and Improves Cognitive Function after Traumatic Brain Injury
Autor: Sarah H. Wang, Myrna L. Cozen, Eric J. Huang, Mary C. Nakamura, Jialing Liu, Deborah Bingham, Christine L. Hsieh, Eréne C. Niemi, Israel F. Charo, Jiasheng Zhang, Chih Cheng Lee
Publikováno v: Journal of neurotrauma, vol 31, iss 20
Traumatic brain injury (TBI) provokes inflammatory responses, including a dramatic rise in brain macrophages in the area of injury. The pathway(s) responsible for macrophage infiltration of the traumatically injured brain and the effects of macrophag
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c7e7162d6082e3602879d46d97ca9580
https://doi.org/10.1089/neu.2013.3252
Zobrazit plný text záznamu
3
Expanded use of aggressive therapies improves survival in early and intermediate hepatocellular carcinoma
Autor: Alexander Monto, James C. Ryan, Hui Shen, Carlos U. Corvera, Robert Lerrigo, Erica L. Trimble, Edith Y. Ho, Myrna L. Cozen
Publikováno v: Ho, EY; Cozen, ML; Shen, H; Lerrigo, R; Trimble, E; Ryan, JC; et al.(2014). Expanded use of aggressive therapies improves survival in early and intermediate hepatocellular carcinoma. HPB, 16(8), 758-767. doi: 10.1111/hpb.12214. UCSF: Retrieved from: http://www.escholarship.org/uc/item/5wk050sc
HPB, vol 16, iss 8
Background Despite the increasing annual incidence of hepatocellular carcinoma (HCC) in the USA, now estimated at 2.7 cases per 100 000 population, only a small proportion of patients receive treatment and 5-year survival rates range from 9% to 17%.
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a9df5b2728f6d003b8fe33406d884d52
Zobrazit plný text záznamu
4
Impaired Lymphocyte Reactivity Measured by Immune Function Testing in Untransplanted Patients with Cirrhosis
Autor: Russell M. Yee, James C. Ryan, Myrna L. Cozen, Mandeep S. Lehil, Hui Shen, Alexander Monto, Catherine Rongey
Publikováno v: Clinical and vaccine immunology : CVI, vol 20, iss 4
The immune function test is an integrated measure of total mitogen-inducible CD4 + T cell metabolic activity in the peripheral blood, and it is used to guide the dosing of immunosuppressive medications after solid organ transplantation. Recently, low
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e96c028766f0ac9d8d80fb05f279637d
https://doi.org/10.1128/cvi.00595-12
Zobrazit plný text záznamu
5
Improved Survival Among all Interferon-α-Treated Patients in HCV-002, a Veterans Affairs Hepatitis C Cohort of 2211 Patients, Despite Increased Cirrhosis Among Nonresponders
Autor: Ramsey Cheung, Ayse Aytaman, Hui Shen, Kyong-Mi Chang, Warren N. Schmidt, Marcos C. Pedrosa, Alexander Monto, Bhupinderjit S. Anand, David E. Kaplan, Timothy R. Morgan, James C. Ryan, Myrna L. Cozen, Christine Pocha, Norbert Bräu
Publikováno v: Digestive diseases and sciences, vol 61, iss 6
BackgroundAs the era of interferon-alpha (IFN)-based therapy for hepatitis C ends, long-term treatment outcomes are now being evaluated.AimTo more fully understand the natural history of hepatitis C infection by following a multisite cohort of patien
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ed71f8ef5637fcdb74451d683322420e
https://europepmc.org/articles/PMC5308124/
Zobrazit plný text záznamu
6
Retreatment of Hepatitis C with Consensus Interferon and Ribavirin After Nonresponse or Relapse to Pegylated Interferon and Ribavirin: A National VA Clinical Practice Study
Autor: Helen S. Yee, Summer Chapman, Hui Shen, Myrna L. Cozen, Kathryn Tortorice, Fran Cunningham, Alexander Monto, Sue Currie
Publikováno v: Digestive Diseases and Sciences. 56:2439-2448
Studies of the retreatment with consensus interferon (CIFN) and ribavirin (RBV) of hepatitis C virus (HCV)-infected patients who failed prior pegylated interferon alfa/ribavirin (PEG-IFN/RBV) have found quite variable efficacy and tolerability of thi
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f06f0430f7977134efba8e0557875be6
https://doi.org/10.1007/s10620-011-1746-3
Zobrazit plný text záznamu
7
Monocyte activation by interferon α is associated with failure to achieve a sustained virologic response after treatment for hepatitis C virus infection
Autor: Valentina A. Shvachko, Joseph M. McCune, Mark R. Segal, M. Michele Manos, Norah A. Terrault, Myrna L. Cozen, Din L. Lin, Lewis L. Lanier, Dennis J. Hartigan-O'Connor, James C. Ryan
Publikováno v: The Journal of infectious diseases, vol 209, iss 10
Background. Interferon α (IFN-α) and ribavirin can induce a sustained virologic response (SVR) in some but not all hepatitis C virus (HCV)-infected patients. The mechanism of effective treatment is unclear. One possibility is that IFN-α differenti
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5f26982eca413fe211b1beb0567bb9d1
https://escholarship.org/uc/item/7k72s56c
Zobrazit plný text záznamu
8
Nonresponse to Interferon-α Based Treatment for Chronic Hepatitis C Infection Is Associated with Increased Hazard of Cirrhosis
Autor: Richard Wu, Myrna L. Cozen, Alexander Monto, Robert Lerrigo, James C. Ryan, Hui Shen, Edward Sheen, Russell M. Yee
Publikováno v: Monto, Alexander; Cozen, ML; Ryan, JC; Shen, H; Lerrigo, R; Yee, RM; et al.(2013). Nonresponse to Interferon-α Based Treatment for Chronic Hepatitis C Infection Is Associated with Increased Hazard of Cirrhosis. UC San Francisco: Retrieved from: http://www.escholarship.org/uc/item/4m8862j2
PLoS ONE
PLoS ONE, Vol 8, Iss 4, p e61568 (2013)
Background The long-term consequences of unsuccessful interferon-α based hepatitis C treatment on liver disease progression and survival have not been fully explored. Methods and Findings We performed retrospective analyses to assess long-term clini
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5ec12d29e58f7ceadfe1955498bf1e63
http://www.escholarship.org/uc/item/4m8862j2
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje